RxDoctor Payments Data

John Bernat

Clinical Genetics (M.D.) · Iowa City, IANPI 1609003011

Payments from drug & device makers

$2,279,202in general payments, 2019–2025

Across 538 payments — averaging $4236.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$1.2M
  • Chiesi USA, Inc.$558K
  • Sanofi US Services Inc.$221K
  • Sanofi$133K
  • Travere Therapeutics, Inc.$114K
  • Mirum Pharmaceuticals, Inc.$24K
  • plus $47K from 4 others
$23in research payments, 2019–2025

Across 1 payment — averaging $22.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi US Services Inc.$23

What the payments were for

  • Consulting fees$25,29256%
  • Speaking & faculty fees$4,60010%
  • Travel & lodging$13,01629%
  • Food & beverage$1,8584%
  • Education$300%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few clinical genetics (m.d.) providers in Iowato place this figure against a meaningful peer group, so we don't.

Other clinical genetics (m.d.) in Iowa City

Where these figures come from

Is this you, or does something look wrong? →